These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 15129240)

  • 1. BioShield defence programme set to fund anthrax vaccine.
    Check E
    Nature; 2004 May; 429(6987):4. PubMed ID: 15129240
    [No Abstract]   [Full Text] [Related]  

  • 2. Project BioShield: what it is, why it is needed, and its accomplishments so far.
    Russell PK
    Clin Infect Dis; 2007 Jul; 45 Suppl 1():S68-72. PubMed ID: 17582574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biodefense: 10 years after. Reinventing Project BioShield.
    Cohen J
    Science; 2011 Sep; 333(6047):1216-8. PubMed ID: 21885752
    [No Abstract]   [Full Text] [Related]  

  • 4. Throwing money at biodefense.
    DeFrancesco L
    Nat Biotechnol; 2004 Apr; 22(4):375-8. PubMed ID: 15060542
    [No Abstract]   [Full Text] [Related]  

  • 5. Anthrax vaccine. NIAID's $233 million problem put on hold.
    Cohen J
    Science; 2003 May; 300(5622):1065. PubMed ID: 12750485
    [No Abstract]   [Full Text] [Related]  

  • 6. Biodefense. House passes plan for drug, vaccine R&D.
    Kaiser J
    Science; 2006 Oct; 314(5796):39. PubMed ID: 17023625
    [No Abstract]   [Full Text] [Related]  

  • 7. Bioterrorism. BioShield is slow to build U.S. defenses against bioweapons.
    Kaiser J
    Science; 2006 Jul; 313(5783):28-9. PubMed ID: 16825542
    [No Abstract]   [Full Text] [Related]  

  • 8. Bioterrorism: what level is the threat and are vaccines the answer?
    Smith LA
    Expert Rev Vaccines; 2004 Oct; 3(5):493-5. PubMed ID: 15485326
    [No Abstract]   [Full Text] [Related]  

  • 9. Biodefence takes its toll.
    Nature; 2003 Jun; 423(6940):571. PubMed ID: 12789296
    [No Abstract]   [Full Text] [Related]  

  • 10. Long wait almost over. Project Bioshield measure nears final approval.
    Fong T
    Mod Healthc; 2004 Jul; 34(29):18-9. PubMed ID: 15301143
    [No Abstract]   [Full Text] [Related]  

  • 11. A no-show vaccine--for a mere $126 million. Deal?
    Pound ET
    US News World Rep; 2001 Oct; 131(18):16. PubMed ID: 11699229
    [No Abstract]   [Full Text] [Related]  

  • 12. Agency set up to tackle bioterror.
    Wadman M
    Nature; 2006 Dec; 444(7121):796-7. PubMed ID: 17167438
    [No Abstract]   [Full Text] [Related]  

  • 13. Expanding Bioshield: a call for caution.
    May T
    Am J Public Health; 2007 Apr; 97 Suppl 1(Suppl 1):S23-5. PubMed ID: 17413075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A dose of reality for the health watchdogs.
    Kluger J
    Time; 2001 Oct; 158(19):65-6. PubMed ID: 11699134
    [No Abstract]   [Full Text] [Related]  

  • 15. Biodefense. Critics question proposed countermeasures agency.
    Kaiser J
    Science; 2005 Nov; 310(5749):755. PubMed ID: 16272086
    [No Abstract]   [Full Text] [Related]  

  • 16. US restrictions limit anthrax networking.
    Ozin A; Bade K; Kaufmann SH
    Nature; 2004 Oct; 431(7011):897. PubMed ID: 15496891
    [No Abstract]   [Full Text] [Related]  

  • 17. Faster detection & better vaccines.
    Occup Health Saf; 2003 Jun; 72(6):70-2. PubMed ID: 12813941
    [No Abstract]   [Full Text] [Related]  

  • 18. US biodefense contracts continue to lure biotechs.
    Shaffer C
    Nat Biotechnol; 2010 Mar; 28(3):187-8. PubMed ID: 20212465
    [No Abstract]   [Full Text] [Related]  

  • 19. HHS budget for HIV/AIDS research increases 8 percent.
    Am Fam Physician; 2002 Mar; 65(6):1017-8. PubMed ID: 11925079
    [No Abstract]   [Full Text] [Related]  

  • 20. Preattack vaccination against anthrax may be cost-effective in certain populations.
    Hopkins RJ; Waytes TA; Zink TK
    Arch Intern Med; 2008 Jan; 168(1):114-5; author reply 115. PubMed ID: 18195210
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.